Thermo Fisher Scientific announces collaboration with Celltrio

Unlock fully automated cell line production

08-Feb-2023 - Thermo Fisher Scientific and Celltrio, a manufacturer of robotics-based solutions for the life sciences industry, have announced their collaboration to bring a fully automated cell culture system to biotherapeutics customers. The collaboration will integrate the Thermo Scientific Momentum ...

Michroma Closes $6.4 Million Seed Round to Bring Novel Food Coloring to Market

Ingredient biotech startup Michroma is on track to expand and scale fungal food colors platform

07-Feb-2023 - Michroma, a leading precision fermentation food ingredient company, today announced it has closed $6.4 million in seed financing. The round will fast-track the company's commercialization of sustainable natural colorants, expand research and development capabilities, and broaden Michroma's ...

An ultra-stable protein nanowire made by bacteria provides clues to combating climate change

07-Feb-2023 - Accelerated climate change is a major and acute threat to life on Earth. Rising temperatures are caused atmospheric methane which is 30-times more potent than CO2 at trapping heat. Microbes are responsible for generating half of this methane and elevated temperatures are also accelerating ...

Artificial Intelligence Improves Efficiency of Genome Editing

Long-term goal: repairing hereditary diseases

06-Feb-2023 - Researchers at the University of Zurich have developed a new tool that uses artificial intelligence to predict the efficacy of various genome-editing repair options. Unintentional errors in the correction of DNA mutations of genetic diseases can thus be reduced. Genome editing technologies offer ...

New cancer vaccine strategy

Defence Therapeutics and CQDM fund the development of a new cancer vaccine platform

06-Feb-2023 - Defence Therapeutics and CQDM announced the launch of a collaborative research project between Université de Montréal (UdeM), the Lady Davis Institute of the Jewish General Hospital and Defence Therapeutics, a Quebec-based biotechnology company specialized in the development of next-generation ...

Start-up wants to bring extinct bird back to life

Colossal Biosciences Secures $150M Series B

02-Feb-2023 - Colossal Biosciences, the world’s first de-extinction company, has announced an oversubscribed $150M Series B financing led by United States Innovative Technology Fund (USIT), with participation from Breyer Capital, WestRiver Group, Bob Nelsen, Animal Capital, Victor Vescovo, In-Q-Tel, Animoca ...

Genome Editing Procedures Optimised

Scientists succeed in boosting the efficiency of CRISPR/Cas9 and related methods and modifying initially inaccessible DNA sequences

01-Feb-2023 - In the course of optimising key procedures of genome editing, researchers from the department of Developmental Biology / Physiology at the Centre for Organismal Studies of Heidelberg University have succeeded in substantially improving the efficiency of molecular genetic methods such as ...

Natural plant toxin as a new broad-spectrum antibiotic

Modifying the sugarcane leaf blight disease trigger - albicidin - so that it is effective against multidrug-resistant hospital pathogens

31-Jan-2023 - In cooperation with scientists from the UK and Poland, the research group led by Prof. Dr. Roderich Süssmuth from the Department of Organic and Biological Chemistry at TU Berlin was able to use electron microscopy at low temperatures to capture snapshots of how albicidin inhibits a vital enzyme ...

Carbios strengthens its management team

Reduce plastic pollution through biorecycling

27-Jan-2023 - Carbios, a pioneer in the development of enzymatic solutions for the recycling of plastic and textile polymers, has strengthened its leadership team with the appointment of Martine BRISSET as Senior Vice President, effective January 1, 2023. Martine BRISSET will lead the Biodegradation Business ...

Sartorius with clear double-digit growth in fiscal 2022

Uncertainties due to the global political and economic situation remain high

27-Jan-2023 - Following extraordinary growth in 2020 and 2021, the life science group Sartorius again outperformed the market in fiscal 2022, achieving its targets for sales revenue and profitability. Both divisions contributed to this development and, according to preliminary figures, recorded double-digit ...